Peptide record

TPDB92027

Transportan 10 Antibacterial Anticancer Antifungal Antiparasitic Blood-Brain Barrier Cell-penetrating Peptides Hemolysis Toxicity modified_plain modified
21 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB92027
Transportan 10
Antibacterial Anticancer Antifungal Antiparasitic Blood-Brain Barrier Cell-penetrating Peptides Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides Delivery and barrier-penetrating peptides
AntiBP3 dbAMP Peptipedia Antifungipept CAFPdb dbAMP 3.0 i2APP B3Pred BBPpredict CellPPD CellPPD-MOD CPPsite3.0 PerseuCPP HemoPI Hemolytic2 PD_Hemolysis
modified_plain
Yes
A 21-aa modified multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, Peptipedia, and other sources, with an available 3D structural model.
C-terminal: Amide group is attached N-terminal: 6-carboxyfluorescein (Fl) was coupled to the N-ter
Sequence
AGYLLGKINLKALAALAKKIL
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
21 reviewed residue count
Amide group is attached Activity
Linear Activity
6-carboxyfluorescein (Fl) was coupled to the N-ter Activity
Cationic Activity
AlaGlyTyrLeuLeuGlyLysIleAsnLeuLysAlaLeuAlaAlaLeuAlaLysLysIleLeu Activity
N[C@@]([H])(C)C(=O)NCC(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(CC(C)C)C(=O)NCC(=O)N[C@@]([H])(CCCCN)C(=O)N[C@@]([H])([C@]([H])(CC)C)C(=O)N[C@@]([H])(CC(=O)N)C(=O)N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(CCCCN)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(CCCCN)C(=O)N[C@@]([H])(CCCCN)C(=O)N[C@@]([H])([C@]([H])(CC)C)C(=O)N[C@@]([H])(CC(C)C)C(=O)O Activity
Evidence Records 5 records
Evidence 1 Activity

Activity

Blood-Brain Barrier
6.3 ± 1.6 micromolar

Target

S. aureus MRSA N315

Assay & Model

100000 CFU/mL
60 mg/kg
Fluorescence microscopy assay
It crosses the BBB.
MIC

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Intravenous
It shows intermediate susceptibility.
Alone
Evidence 2 Activity

Activity

Blood-Brain Barrier
0.8 ± 0.3 micromolar

Target

S. aureus MRSA 12673

Assay & Model

100000 CFU/mL
60 mg/kg
Fluorescence microscopy assay
It crosses the BBB.
MIC

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Intravenous
It shows high sensitivity
Combined with Vanomycin
Evidence 3 Activity

Activity

Blood-Brain Barrier
3.1 ± 0.8 micromolar

Target

S. aureus MRSA hetero-VISA 6347b

Assay & Model

100000 CFU/mL
60 mg/kg
Fluorescence microscopy assay
It crosses the BBB.
MIC

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Intravenous
It shows intermediate susceptibility.
Combined with Vanomycin
Evidence 4 Activity

Activity

Blood-Brain Barrier
6.3 ± 1.7 micromolar

Target

Enterococcus faecium 3934825

Assay & Model

60 mg/kg
Fluorescence microscopy assay
It crosses the BBB.
MIC

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Intravenous
It shows intermediate susceptibility.
Combined with Vanomycin
Evidence 5 Activity

Activity

Blood-Brain Barrier
25.0 ± 6.9 micromolar

Target

Enterococcus faecalis 3937158

Assay & Model

60 mg/kg
Fluorescence microscopy assay
It crosses the BBB.
MIC

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Intravenous
It shows the resistance
Combined with Vanomycin
Additional Detail Fields 1 fields
Intravenous